Is Aortic Insufficiency the Same as Aortic Regurgitation?

Aortic insufficiency and aortic regurgitation are two names for the same condition: a leaky aortic valve that allows blood to flow backward from the aorta into the left ventricle during the heart’s relaxation phase.¹ You will also occasionally see the term “aortic incompetence” in older literature. All three phrases describe the same problem, and you can treat them as interchangeable when reading a doctor’s note, a textbook, or a diagnostic report. The reason multiple names persist is partly historical convention and partly regional preference, but the underlying pathology, workup, and treatment are identical regardless of which label appears on your chart.

Why Multiple Names Exist

“Regurgitation” emphasizes the backward flow of blood, while “insufficiency” emphasizes the valve’s failure to do its job. A third, older term, “incompetence,” also highlights the valve’s inability to close properly. None of these words signals a different severity or a different disease mechanism. Cardiologists in North America tend to favor “aortic regurgitation” (often abbreviated AR), and that is the term you will see in most current guidelines and journal papers. European and older American literature sometimes uses “aortic insufficiency” (AI). One large surgical pathology study of 225 cases, for instance, used “aortic insufficiency” in its title and “aortic regurgitation” and “aortic incompetence” interchangeably throughout its findings.² If your medical records use one term and a second opinion uses another, there is no cause for alarm. They are talking about the same valve.

What Happens Inside the Heart

The aortic valve sits between the left ventricle and the aorta. In a healthy heart, the valve opens to let blood rush out during each heartbeat, then snaps shut so nothing leaks back. When the valve does not seal completely, some blood slips backward into the ventricle during the resting phase between beats.¹ That backward leak means the ventricle has to pump the normal volume of blood plus the extra volume that leaked back in, creating a chronic volume overload.

The leak can originate from problems with the valve leaflets themselves or from problems with the aortic root, the section of the aorta right above the valve. When the root stretches or balloons outward, it pulls the leaflets apart so they can no longer meet in the middle.³ Either way, the downstream effect is the same: blood flows the wrong direction, the heart works harder, and if left uncorrected, the left ventricle gradually enlarges and weakens.

Common Causes

In the large surgical pathology study mentioned above, the four most frequent causes of AR among 225 patients were postinflammatory disease (about 46%), aortic root dilatation (roughly 21%), incomplete closure of a congenitally bicuspid aortic valve (around 20%), and infective endocarditis (about 9%).² The proportions shift depending on the population studied and the era, but a few broad categories account for most cases:

Postinflammatory (rheumatic) disease: Scarring from rheumatic fever thickens and retracts the valve leaflets, preventing them from closing. This remains one of the most common causes worldwide, though it is less prevalent in countries where acute rheumatic fever is rare.
Bicuspid aortic valve: About 1–2% of people are born with two leaflets instead of the usual three. Pure severe aortic regurgitation can complicate this malformation even without any infection or narrowing of the valve, though that scenario is less well recognized than stenosis or endocarditis in bicuspid valve patients.⁴ In necropsy studies, infective endocarditis was identified as a primary cause of aortic insufficiency in patients with bicuspid valves, with incidence ranging from about 15 to 40 percent.⁵
Aortic root dilatation: Conditions that weaken the aortic wall, including age-related degeneration, chronic high blood pressure, and heritable connective tissue disorders, can cause the root to widen enough to separate the leaflets.
Infective endocarditis: Bacteria colonizing the valve can erode or perforate a leaflet, creating an acute leak.

Connective Tissue Disorders and the Aortic Root

Heritable conditions like Marfan syndrome and Loeys-Dietz syndrome deserve a separate mention because they produce a distinctive pattern of cardiovascular problems. Both disorders involve defects in connective tissue signaling and tend to co-occur with thoracic aortic aneurysm, mitral valve prolapse, and aortic root dilatation with regurgitation.⁶ In these patients, the valve leaflets may be perfectly formed, but the root stretches so far that the leaflets cannot meet. Surveillance typically involves regular imaging to track root diameter and intervene before a dissection or severe leak develops.

Acute Versus Chronic Leak

The distinction between acute and chronic AR matters far more clinically than the choice between calling it “insufficiency” or “regurgitation.” Acute AR, as happens with sudden leaflet destruction from endocarditis or aortic dissection, is a medical emergency. The left ventricle has had no time to adapt: diastolic pressures spike, the mitral valve may close prematurely, and cardiac output can drop dangerously.⁷

Chronic AR is a different story. The ventricle slowly remodels over months to years, enlarging its chamber to accommodate the extra volume and increasing stroke volume so that forward blood flow stays adequate. The classic exam findings of chronic AR, a widened pulse pressure and a low diastolic blood pressure, reflect this remodeling.⁷ Wide pulse pressure on its own has a broad list of possible causes, but aortic regurgitation is one of the most recognized.⁸

The stiffness of the ventricle also plays a role. In experimental modeling, a stiffer left ventricle facing even mild AR saw up to a threefold reduction in forward flow through the mitral valve compared with a more compliant ventricle, and required substantially more cardiac work to compensate for the lost volume.⁹ This helps explain why patients who already have a stiff heart from long-standing high blood pressure or aortic stenosis tolerate even small amounts of AR poorly.

How the Heart Remodels

In chronic AR, the left ventricle undergoes a type of growth called eccentric hypertrophy, where the chamber dilates and the walls thicken somewhat, though not as dramatically as in pure pressure overload. This remodeling is initially adaptive: it normalizes wall stress and preserves the heart’s pumping ability despite the extra volume load.¹⁰ Animal models of AR have shown that the heart’s workload increases markedly, with coronary blood flow rising by more than 60 percent to supply the growing muscle mass, while the chamber dilates and individual heart muscle cells enlarge.¹¹

The tricky part is that this compensation has a shelf life. Eventually the ventricle can tip from healthy remodeling into genuine heart failure, and because the decline happens gradually, symptoms often lag behind objective evidence of dysfunction. Disease progression is variable and frequently insidious, which is why symptoms alone are a poor guide to how much trouble the valve is really causing.¹² Strain-rate imaging studies have found that longitudinal heart muscle function is reduced in both pressure overload (aortic stenosis) and volume overload (aortic regurgitation) to a similar degree, suggesting that both patterns of overload are equally damaging to the ventricle over time.¹³

How AR Is Diagnosed and Graded

Echocardiography, a heart ultrasound, is the primary tool for evaluating AR.¹⁴ Color Doppler imaging shows the jet of blood flowing backward through the valve, and several measurements help grade the leak as mild, moderate, or severe. One commonly used measurement is the vena contracta, the narrowest width of the regurgitant jet as it passes through the valve. Two-dimensional and three-dimensional assessments of the vena contracta correlate strongly with each other and with other markers of severity like regurgitant volume.¹⁵

When echocardiographic data is inconclusive or the images are suboptimal, cardiac magnetic resonance (CMR) imaging can step in.¹⁴ CMR can directly measure regurgitant fraction, which is the percentage of blood that leaks back per beat. In one study, patients with a regurgitant fraction above roughly one-third progressed to surgery in about 85 percent of cases, most within three years, compared with only 8 percent of those below that threshold.¹⁶ Combining regurgitant fraction with ventricle size gave the strongest predictive power for identifying who would need surgery. Grading across imaging methods is being harmonized so that an echocardiographic grade and a CMR grade use consistent cutoffs.¹⁷

Medical Treatment and Its Limits

Because AR increases the workload on the heart by raising the volume it must pump, a logical idea has been to use blood-pressure-lowering drugs (vasodilators) to reduce that burden. In acute, severe AR, short-term afterload reduction with intravenous agents like nitroprusside can meaningfully improve cardiac output and reduce the amount of backward leak, making it a useful bridge to surgery.¹⁸

Long-term oral vasodilator therapy, however, has not lived up to the same promise. A well-known trial comparing nifedipine and enalapril against placebo in patients with asymptomatic severe AR and normal pump function found that neither drug reduced or delayed the need for valve replacement. They also did not shrink the ventricle, reduce the regurgitant volume, or improve heart function over time.¹⁹ Current practice reflects this: there is no pill that “fixes” chronic AR. Medical therapy can manage blood pressure and symptoms, but the definitive treatment for severe AR is surgical correction.

When Surgery Is Needed

The timing of valve surgery in chronic AR has been one of the trickier judgment calls in cardiology. Operate too early, and the patient takes on procedural risk they did not yet need. Wait too long, and the ventricle sustains irreversible damage. Guidelines from the American Heart Association and American College of Cardiology have historically recommended surgery once symptoms develop or once the left ventricle begins to dilate or weaken past certain thresholds. But more recent evidence suggests that operating earlier than those cutoffs may improve long-term survival.²⁰

Long-term outcomes after aortic valve replacement depend heavily on how well the left ventricle is working before surgery. Patients who go into the operation with normal pump function fare considerably better than those with reduced function. In one large study, ten-year survival was about 70 percent among those who had normal function going in, compared with roughly 56 percent in those with moderately reduced function and about 41 percent in those with severely reduced function. Heart failure at ten years followed the same gradient.²¹ More recently, preoperative left ventricular dimensions, particularly end-systolic diameter, have emerged as an additional marker that helps predict who will do well after surgery.²² The message is consistent across studies: the earlier you catch declining heart function and intervene, the better the long-term outlook.²³

Catheter-Based Valve Replacement for AR

Transcatheter aortic valve replacement, or TAVR, has transformed the treatment of aortic stenosis (a narrowed valve) over the past two decades, but applying it to pure aortic regurgitation has been a harder engineering problem. A stenotic valve provides a calcified ring that anchors the new device in place; a regurgitant valve often lacks that scaffolding. Early attempts saw high complication rates, including valve migration and residual leaks. Newer dedicated devices, specifically designed for AR rather than stenosis, have shown improved results with fewer complications and better survival.²⁴

Still, open surgical valve replacement remains the standard for most patients with pure AR who are fit enough for surgery. In a national comparison of more than 11,000 patients with pure AR, catheter-based replacement had comparable 30-day mortality but carried a higher adjusted long-term risk of death and a higher chance of needing a repeat procedure compared with open surgery over a median follow-up of about two and a half years.²⁵ For now, TAVR for AR is generally reserved for patients who are too high-risk or too frail for conventional surgery, though the technology continues to evolve rapidly.

Classic Physical Exam Findings

Chronic AR has inspired one of the longest lists of eponymous physical signs in all of medicine. A review in the American Journal of Cardiology catalogued twelve named signs, at least one of which was named after a patient rather than the physician who described it.²⁶ Most of these signs are manifestations of wide pulse pressure: a bounding, forceful pulse that creates visible pulsations in unusual places. You might see a bobbing of the head in time with the heartbeat, or notice the nail beds changing color with each pulse when gentle pressure is applied to the fingertip. These signs are useful teaching tools and occasionally clinch a bedside diagnosis, but in modern practice, imaging has made them more of a historical curiosity than a diagnostic necessity.

What the physical exam can still do well is raise suspicion. A high-pitched, blowing murmur heard best when you sit forward and exhale, combined with a wide pulse pressure, is a classic combination that prompts the echocardiogram. The exam is less reliable for grading severity, which is where the imaging tools described earlier take over.